Who am I? Autobiographical retrieval improves access to self-concepts

It is considered that an individual's current self-concept plays a crucial role in guiding the retrieval of autobiographical memory. Using a novel fluency paradigm, the present research examined whether or not the reverse is also true, that is, does memory retrieval influence the description of the conceptual self? Specifically, this study examined the effect of prior autobiographical reverie on the subsequent retrieval of stored self-concepts. Participants wrote a description of a personally relevant memory or a control topic (of no relevance to the self), following which they had 60 seconds to generate as many self-defining statements as possible, each beginning with I am. Participants engaging in autobiographical retrieval generated significantly more statements than those in the control condition, suggesting that autobiographical retrieval increased access to self-concepts. Type of statement also varied according to group. Participants in the autobiographical memory condition were more likely to conceptualise themselves in relation to their psychological traits, and this was replicated in a second experiment conducted online. Findings support the idea that self and episodic memory are highly related constructs, and are discussed in relation to implications for individuals with autobiographical memory deficits

Estimating the age of Calliphora vicina eggs (Diptera: Calliphoridae): determination of embryonic morphological landmarks and preservation of egg samples

ORCID No. 0000-0002-8917-9646© The Author(s) 2016. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The attached file is the published version of the article

Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients

Background Patients with acute medical illnesses are at prolonged risk for venous thrombosis. However, the appropriate duration of thromboprophylaxis remains unknown. Methods Patients who were hospitalized for acute medical illnesses were randomly assigned to receive subcutaneous enoxaparin (at a dose of 40 mg once daily) for 10±4 days plus oral betrixaban placebo for 35 to 42 days or subcutaneous enoxaparin placebo for 10±4 days plus oral betrixaban (at a dose of 80 mg once daily) for 35 to 42 days. We performed sequential analyses in three prespecified, progressively inclusive cohorts: patients with an elevated d-dimer level (cohort 1), patients with an elevated d-dimer level or an age of at least 75 years (cohort 2), and all the enrolled patients (overall population cohort). The statistical analysis plan specified that if the between-group difference in any analysis in this sequence was not significant, the other analyses would be considered exploratory. The primary efficacy outcome was a composite of asymptomatic proximal deep-vein thrombosis and symptomatic venous thromboembolism. The principal safety outcome was major bleeding. Results A total of 7513 patients underwent randomization. In cohort 1, the primary efficacy outcome occurred in 6.9% of patients receiving betrixaban and 8.5% receiving enoxaparin (relative risk in the betrixaban group, 0.81; 95% confidence interval [CI], 0.65 to 1.00; P=0.054). The rates were 5.6% and 7.1%, respectively (relative risk, 0.80; 95% CI, 0.66 to 0.98; P=0.03) in cohort 2 and 5.3% and 7.0% (relative risk, 0.76; 95% CI, 0.63 to 0.92; P=0.006) in the overall population. (The last two analyses were considered to be exploratory owing to the result in cohort 1.) In the overall population, major bleeding occurred in 0.7% of the betrixaban group and 0.6% of the enoxaparin group (relative risk, 1.19; 95% CI, 0.67 to 2.12; P=0.55). Conclusions Among acutely ill medical patients with an elevated d-dimer level, there was no significant difference between extended-duration betrixaban and a standard regimen of enoxaparin in the prespecified primary efficacy outcome. However, prespecified exploratory analyses provided evidence suggesting a benefit for betrixaban in the two larger cohorts. (Funded by Portola Pharmaceuticals; APEX ClinicalTrials.gov number, NCT01583218. opens in new tab.

Conserved genes and pathways in primary human fibroblast strains undergoing replicative and radiation induced senescence

Additional file 3: Figure S3. Regulation of genes of Arrhythmogenic right ventricular cardiomyopathy pathway during senescence induction in HFF strains Genes of the “Arrhythmogenic right ventricular cardiomyopathy” pathway which are significantly up- (green) and down- (red) regulated (log2 fold change >1) during irradiation induced senescence (120 h after 20 Gy irradiation) in HFF strains. Orange color signifies genes which are commonly up-regulated during both, irradiation induced and replicative senescence

Reading Companion: The Technical and Social Design of an Automated Reading Tutor

This paper describes IBM’s automatic reading tutor system, the Reading Companion. The reading tutor aims to improve the literacy skills of beginning readers, both children and adults, and help adults who are non-native speakers of English to learn the language. We describe Reading Companion’s architecture, which allows a large, globally distributed reading companion community to create and share new reading material. We also report substantial accuracy improvements in recognizing children’s speech gained by training the recognizer on the IBM Kidspeak corpus, a newly developed corpus of children’s speech